These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 22069473)

  • 1. Complement and the alternative pathway play an important role in LPS/D-GalN-induced fulminant hepatic failure.
    Sun S; Guo Y; Zhao G; Zhou X; Li J; Hu J; Yu H; Chen Y; Song H; Qiao F; Xu G; Yang F; Wu Y; Tomlinson S; Duan Z; Zhou Y
    PLoS One; 2011; 6(11):e26838. PubMed ID: 22069473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C5a/C5aR pathway is essential for up-regulating SphK1 expression through p38-MAPK activation in acute liver failure.
    Lei YC; Lu CL; Chen L; Ge K; Yang LL; Li W; Wu YH
    World J Gastroenterol; 2016 Dec; 22(46):10148-10157. PubMed ID: 28028363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced hepatic injury in Toll-like receptor 4-deficient mice following D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure.
    Ben Ari Z; Avlas O; Pappo O; Zilbermints V; Cheporko Y; Bachmetov L; Zemel R; Shainberg A; Sharon E; Grief F; Hochhauser E
    Cell Physiol Biochem; 2012; 29(1-2):41-50. PubMed ID: 22415073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
    Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
    Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A5 alleviates LPS/D-GalN-induced fulminant liver failure in mice by inhibiting TLR4-mediated NF-κB pathway.
    Tao YC; Wang ML; Wu DB; Luo C; Tang H; Chen EQ
    J Transl Med; 2019 May; 17(1):151. PubMed ID: 31077206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement inhibition alleviates paraquat-induced acute lung injury.
    Sun S; Wang H; Zhao G; An Y; Guo Y; Du L; Song H; Qiao F; Yu H; Wu X; Atkinson C; Jiang S; Tomlinson S; Zhou Y
    Am J Respir Cell Mol Biol; 2011 Oct; 45(4):834-42. PubMed ID: 21421909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
    Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
    FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective blockade of mGlu5 metabotropic glutamate receptors is hepatoprotective against fulminant hepatic failure induced by lipopolysaccharide and D-galactosamine in mice.
    Jesse CR; Wilhelm EA; Bortolatto CF; Savegnago L; Nogueira CW
    J Appl Toxicol; 2009 May; 29(4):323-9. PubMed ID: 19153979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
    Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
    Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
    Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
    Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoprotective effects of syringin on fulminant hepatic failure induced by D-galactosamine and lipopolysaccharide in mice.
    Gong X; Zhang L; Jiang R; Wang CD; Yin XR; Wan JY
    J Appl Toxicol; 2014 Mar; 34(3):265-71. PubMed ID: 23620140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoprotective effects of erythropoietin on D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Yang XF; He Y; Li HY; Liu X; Chen H; Liu JB; Ji WJ; Wang B; Chen LN
    Mol Med Rep; 2014 Jul; 10(1):555-9. PubMed ID: 24788561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sesamin ameliorates lipopolysaccharide/d-galactosamine-induced fulminant hepatic failure by suppression of Toll-like receptor 4 signaling in mice.
    Ma L; Gong X; Kuang G; Jiang R; Chen R; Wan J
    Biochem Biophys Res Commun; 2015 May; 461(2):230-6. PubMed ID: 25866179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of agmatine against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure in mice.
    El-Agamy DS; Makled MN; Gamil NM
    Inflammopharmacology; 2014 Jun; 22(3):187-94. PubMed ID: 23989863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
    Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
    J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 17A plays a role in lipopolysaccharide/D-galactosamine-induced fulminant hepatic injury in mice.
    Furuya S; Kono H; Hara M; Hirayama K; Sun C; Fujii H
    J Surg Res; 2015 Dec; 199(2):487-93. PubMed ID: 26141869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inflammasome activation in D-galactosamine and lipopolysaccharide-induced acute liver failure: role of heme oxygenase-1.
    Kim SJ; Lee SM
    Free Radic Biol Med; 2013 Dec; 65():997-1004. PubMed ID: 23994575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
    Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
    Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palmatine attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure in mice.
    Lee WC; Kim JK; Kang JW; Oh WY; Jung JY; Kim YS; Jung HA; Choi JS; Lee SM
    Food Chem Toxicol; 2010 Jan; 48(1):222-8. PubMed ID: 19818826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibiting the expression of hepatocyte nuclear factor 4 alpha attenuates lipopolysaccharide/D-galactosamine-induced fulminant hepatic failure in mice.
    Chen EQ; Gong DY; Leng XH; Bai L; Liu C; Wang LC; Tang H
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):624-9. PubMed ID: 23232634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.